TRAF2 and ablepharon macrostomia syndrome: He et al. profiled AMS symptoms, clinical indexes, and plasma proteomes of AMS, found the pathogenic role of RET to AMS, and suggested ADAM15, PHGDH, and TRAF2 as protective, predictive, and diagnostic biomarkers, respectively [40].